How innovators are using tech to get drug dosing right
A few months ago, Rhodes Hambrick, a pediatric neurologist, was at a party in Chicago when a man with a slight cold asked how much Sudafed he should take. He told him he could take two, but he’d probably feel jittery and should probably just take one pill. Dissatisfied with this answer, the man put the question to ChatGPT, which told him to take two pills. He took two and twenty minutes later was surprised to find he did indeed feel jittery.
“You're not gonna have a stroke from taking two Sudafed,” Hambrick told me. “But I happen to have some clinical experience here.”
Ironically, Hambrick has tested AI’s ability to dose patients. He found that while large language models get dosing right most of the time, when they get it wrong, the results can prove fatal. In 2025, he challenged six LLMs (ChatGPT, Claude, Google Gemini, Microsoft Copilot, OpenEvidence, and Perplexity) to accurately dose antibiotics for complex patients either on dialysis or with impaired kidney function. The questions were intentionally difficult and though many answers were right, LLMs varied in their recommendations widely. Hambrick said what was really interesting is that even in cases where LLMs offered up a wrong dose, they referenced the right information.
“It would say all the right things, but then do the wrong math,” he said.
Still, doctors are keen to use AI to help them fix a common cause of patient harm: medication errors. Just as patients are turning to AI with their medical questions, so too are doctors. Treatment and disease management accounted for a third of physicians’ OpenEvidence queries, according to a recent investigation published in JAMA. This included selecting the therapy, medication dosing, and managing patient safety.
Why this matters: AI has the potential to help doctors, who are frequently burned out or under strain, to reduce medication errors. But it is not as simple as asking ChatGPT to suggest a dose. It potentially requires building fit-for-purpose tech to handle dosing or taking a different approach to AI prompting.
In this article we discuss:
- The research on AI’s ability to dose medication
- How one company built a fit for purpose tool
- Tips on how doctors can better prompt AI to get more accurate doses
- What history tells us about how we should be building for health care
Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?